In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

JHP Pharmaceuticals buys NitroMed's BiDil for $26.3mm; ends

Executive Summary

JHP Pharmaceuticals has bought all of NitroMed's BiDil (isosorbide dinitrate/hydralazine) assets for $24.5mm in cash plus $1.8mm for inventory and will assume certain liabilities.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Marketing (Licensing)
    • Product Purchase

Related Companies

UsernamePublicRestriction

Register